Cargando…

Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results

OBJECTIVE: Systemic lupus erythematosus (SLE) is an autoimmune systemic disease and its pathogenesis has not yet been completely clarified. Patients with SLE show a deranged lipid metabolism, which can contribute to the immunopathogenesis of the disease and to the accelerated atherosclerosis. Resolv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarini, Luca, Bisogno, Tiziana, Margiotta, Domenico Paolo Emanuele, Piccoli, Alessandra, Angeletti, Silvia, Laudisio, Alice, Ciccozzi, Massimo, Afeltra, Antonella, Maccarrone, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215556/ https://www.ncbi.nlm.nih.gov/pubmed/30420970 http://dx.doi.org/10.1155/2018/5264195

Ejemplares similares

The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus
por: Margiotta, Domenico Paolo Emanuele, et al.
Publicado: (2017)

Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus
por: Margiotta, Domenico Paolo Emanuele, et al.
Publicado: (2018)

Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis
por: Gigante, Antonietta, et al.
Publicado: (2021)

Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
por: Norling, Lucy V., et al.
Publicado: (2016)

Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
por: Norling, Lucy V., et al.
Publicado: (2023)

Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study
por: Navarini, Luca, et al.
Publicado: (2018)

Polyunsaturated fatty acids: any role in rheumatoid arthritis?
por: Navarini, Luca, et al.
Publicado: (2017)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
por: Margiotta, Domenico Paolo Emanuele, et al.
Publicado: (2018)

Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress
por: Leuti, Alessandro, et al.
Publicado: (2019)

Erratum to “Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress”
por: Leuti, Alessandro, et al.
Publicado: (2019)

Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders
por: Han, Yong-Hyun, et al.
Publicado: (2021)

Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
por: Salazar, Juan, et al.
Publicado: (2022)

Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases
por: Tang, Shi, et al.
Publicado: (2018)

The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study
por: Laudisio, Alice, et al.
Publicado: (2019)

Exercise-induced specialized proresolving mediators stimulate AMPK phosphorylation to promote mitochondrial respiration in macrophages
por: Calderin, Ernesto Pena, et al.
Publicado: (2022)

Anti-Inflammatory Effect of Specialized Proresolving Lipid Mediators on Mesenchymal Stem Cells: An In Vitro Study
por: AlZahrani, Shahd, et al.
Publicado: (2022)

Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review
por: Romano, Mario, et al.
Publicado: (2019)

Editorial: Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders
por: Sousa, Teresa, et al.
Publicado: (2023)

The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study: GIRRCS=Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale
por: Fasano, Serena, et al.
Publicado: (2018)

Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution
por: Fredman, Gabrielle, et al.
Publicado: (2011)

Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins
por: Cianci, Eleonora, et al.
Publicado: (2016)

Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators*
por: Tsoyi, Konstantin, et al.
Publicado: (2016)

Lipoxins and Resolvins in Patients With Pancreatic Cancer: A Preliminary Report
por: Blogowski, Wojciech, et al.
Publicado: (2022)

Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
por: Serhan, Charles N., et al.
Publicado: (2009)

Human Milk Proresolving Mediators Stimulate Resolution of Acute Inflammation
por: Arnardottir, Hildur, et al.
Publicado: (2015)

Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca(2+) Handling and NRF2 Activation
por: Val-Blasco, Almudena, et al.
Publicado: (2022)

Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p
por: Cheng, Tao, et al.
Publicado: (2021)

Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study
por: Iacono, Daniela, et al.
Publicado: (2019)

Imbalance of proresolving lipid mediators in persistent allodynia dissociated from signs of clinical arthritis
por: Allen, Benjamin L., et al.
Publicado: (2020)

Systemic lupus erythematosus and thrombosis
por: Bazzan, Mario, et al.
Publicado: (2015)

2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus
por: Navarini, Luca, et al.
Publicado: (2022)

BIONOTE as an Innovative Biosensor for Measuring Endocannabinoid Levels
por: Grasso, Simone, et al.
Publicado: (2021)

Toll-like receptors in autoimmunity with special reference to systemic lupus erythematosus
por: Pradhan, Vandana D., et al.
Publicado: (2012)

Macrophage-Associated Lipin-1 Promotes β-Oxidation in Response to Proresolving Stimuli
por: Schilke, Robert M., et al.
Publicado: (2020)

Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation
por: Sekheri, Meriem, et al.
Publicado: (2022)

Resolvins and inflammatory pain
por: Sommer, Claudia, et al.
Publicado: (2011)

Resolvins on the way to resolution
por: Ward, Peter A.
Publicado: (2015)

Stereoselective Synthesis and Structural Confirmation of the Specialized Pro-Resolving Mediator Resolvin E4
por: Reinertsen, Amalie Føreid, et al.
Publicado: (2021)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Cannot write session to /tmp/vufind_sessions/sess_82474qrng4ub9kja3cp533lmg0